The Company is the only privately-held supplier of e-cigarettes and vaping products among the top 10 brands in the U.S. The brand offers consumers a simple and satisfying, value-based alternative to competing e-cigarettes. The Company’s success is driven in part by its focus on its high quality products at a value price point to core Tobacco users. The brand’s ability to compete on price and product performance has fueled its C-store leadership position in volume-per-location as compared with competitors.
Revenue is on track to increase 19% in 2018 and expected to grow 54% in 2019 due to enthusiastic consumer response to the Company’s new product line launched in June of this year. As of July 2018, demand for the new product line has outpaced its supply in the limited markets where it was made available for retail sale. Management expects 25,000 units of these new products will be sold in 2018.
The Company produces precision components for a variety of end-products including medical equipment and diagnostic devices, filtration and fire suppression systems for aerospace, firearm components, fiber optic tools, and many others. The Company is well-positioned to grow its medical device business even further.
The Company serves regional and global manufacturers across the U.S. with capabilities ranging from prototyping to production, CNC milling, CNC turning, CNC swiss turning, fabrication and assembly. Management has focused on building a first-class business structure to facilitate growth and manufacture superior-quality products. Over the life of the Company, management has continually invested in new machinery and equipment upgrades to meet growing demand, in addition to developing new services and adding capabilities.
The Company operates with 44 employees from a 50,000-square-foot, state-of-the-art facility. There is about 8,000 square feet available in which to add new equipment and capacity in personnel and infrastructure. The principals, who all have operational responsibilities, as well as the Company’s senior management team, are prepared to work with a new owner to grow the business to its full potential.
This is a remarkably efficient and lean operation with only 11 employees in addition to the two active partners. Both partners are amenable to continue working at the Company indefinitely, or as long as necessary to ensure a smooth transition and transfer of know-how.
The Company’s revenues are derived from physical medicine, family practice and expert testimony. Each line of business cross-refers patients creating an end-to-end experience and one-stop shop for patients. The Company’s treatment and business model is based on close coordination among a group of medical professionals including physicians, chiropractors, physical therapists, massage therapists and physical therapy assistants. In addition, the Company operates a full-service pharmacy as well as a durable medical equipment department. The model ensures the delivery of high-quality medical care and also results in operational and billing efficiencies. In 2017, there were nearly 41,000 patient visits.
Near-term expansion opportunities include extending the portfolio of medical services, expanding Cash-based aesthetic procedures, opening new offices and rolling out off-site care programs. Competition is weak, as other providers specialize in only one or two of the domains covered by the Company. In general, competitors do not offer the same degree of comprehensive services, and hospital systems offer less personalized and often inferior patient care.
The Company has built a respected service-delivery ecosystem and a roster of marquis customers. In addition to storing and transporting sets for productions, the Company builds sets, props and stages, and delivers them anywhere they are needed. The top 10 customers have been active for an average of 10 years, and there is a well-diversified customer base with no concentration.
With decades of experience in the entertainment industry delivering time-sensitive projects within high-pressure environments, the Company is able to retain repeat customers such as Disney, NBC Universal, ABC, Nickelodeon and Activision. Management believes there is no trucking or storage company that has the size, ability or capacity to accommodate the size and sheer volume of projects that the Company regularly handles.
The Company has only begun to realize its potential to become the dominant player in a growing industry. By leveraging its unique set of capabilities in producing and managing large amounts of theatrical assets, the Company could increase its reach geographically as well as into gaming, theme parks and corporate TV and commercials.
The Company sources and distributes clinical trial, biologic and specialty drugs to pharmaceutical and biotech companies. Its customer base consists of about 285 major companies in the U.S. and abroad in the branded, generic, biotech and pharmaceutical industries. Customers include virtually all major generic drug manufacturers.
The Company has a distinct competitive advantage in a segment where customer confidentiality is key and multiple lots with different expiration dates are required to successfully perform clinical trials. Its 15 vendors have access to manifold suppliers of their own, including distributors, specialty pharmacy relationships and wholesalers. The supply chain can source as far down as the retail level, with access to almost 500 drug depots/pharmacies if necessary.
The Company is an economical one-stop shop for customers who can find design, machining, castings, tooling and painting and superior- quality finished products under one roof. The Company served about 90 + active customers over the past three years, most of who are
aerospace and defense OEMs or suppliers to these markets. There are five long-term agreements with key customers. The majority of sales are to U.S.-based companies, with about 5% from customers located in Europe.
The decline in 2016 was an anomaly due to the loss of one major program due to redesign and completion of a large military program accompanying heavy R&D investment in proprietary foam process. Going forward, the sales of foam products are expected to make up nearly 50% of the total product mix in 2018 and 2019. Accordingly, management expects gross margins to be 40% and higher due mainly to the foam sales but also because the casting and machining projects now in the pipeline are once again higher margin jobs.
The facilities are utilizing about 50-60% of their aggregate production capacity, offering an acquirer significant growth potential. In addition, management has identified several privately-held potential acquisition targets in North America that would collectively form a $150 million + business.
Located in one of the largest urban regions in the U.S., the Company serves five densely-populated counties, providing a broad range of medical equipment. Equipment rentals account for 92% of revenue, and sales of supplies are the remainder. Core products include electric hospital beds, wheelchairs, oxygen concentrators, oxygen tanks, aspirators, reclining chairs, over bed tables, walkers and commodes, among others.
The Company is on track to generate 2018 is $6.2 million, an increase of 11% over 2017, with approximately $2.2 million in adjusted EBITDA.
One of North America’s premier outdoor furniture brands, the Company designs and manufactures a recognized line of outdoor furniture and accessories. Products are sold through over 530 stores worldwide and on certain websites. The Company is forecasted to grow at a CAGR of 46.8% and outperforms competitors on pricing for high-quality products while delivering superior value to customers and consumers.
The Company owns several proprietary designs and processes and has achieved a high level of operational efficiency by investing in automation and limiting its product line. Virtually all raw materials come from the Company’s own waste, post-industrial waste, and wide-spec and off-spec resins supplied by resin producers. The owner is willing to stay post-transaction to assist with building a new facility to accommodate significant expansion and will work with a new owner on business development.
The Company is one of the largest providers of family preservation, mental health and crisis management services in its densely populated and growing market. Last year the Company had service contracts with two area school systems totaling 41 schools, and management expects that number to increase to 48-52 schools in the 2018-2019 school year. The Company has multi-year service contract with a major state agencies.
The Company has a partnership with an outside agency to train its staff members in the use of trauma-focused cognitive behavioral therapy. In addition, the Company recently entered into a partnership with an IT company to explore the use of predictive analytics. The system uses feedback and voice recognition emotional scales from families and other data to help analyze family dynamics and improve services and efficiency.
The Company has experienced consistent year-over-year growth from 2015 through 2017 at a compounded annual growth rate of 7%. Based on new service lines being rolled out and an expanding geographic footprint, management projects revenues will achieve $8.5 million in 2018 and $10.2 million in 2019.
The Company fills a fundamental, compelling need by business owners for better financial visibility, strategic support and access to best-in-class domain expertise and educational resources to reach their business goals. The Company’s diverse IPportfolio includes one patent-pending software application and numerous trademarks and copyrights on its books and other educational resources. The business model has demonstrated an ability to expand throughout the U.S. and offers an ideal synergy for a buyer targeting privately-held, mid-market companies.
The Company’s sole focus is delivering high-value services and fostering a community of advisors supported by professional staff dedicated to continuous improvement. From 2016 to 2017 revenues increased 11% due to the number of new members and an increase in the total billings by active members. Into 2018 and beyond, the Company is focused on continuously growing the member base. The Company could generate significant leads and new business for the right strategic acquirer.